In conclusion, for women with PCOS undergoing the GnRH antagonist protocol, use of the four types of Gn leads to a similar clinical pregnancy rate in the fresh IVF/ICSI-ET cycle, but it seems that the use of HP-hMG leads to the highest clinical pregnancy rate numerically. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.